These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19386495)

  • 21. Total synthesis of anticoagulant pentasaccharide fondaparinux.
    Li T; Ye H; Cao X; Wang J; Liu Y; Zhou L; Liu Q; Wang W; Shen J; Zhao W; Wang P
    ChemMedChem; 2014 May; 9(5):1071-80. PubMed ID: 24729477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site.
    Cesaretti M; Luppi E; Maccari F; Volpi N
    Glycobiology; 2004 Dec; 14(12):1275-84. PubMed ID: 15253929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modular synthesis of heparin oligosaccharides.
    Orgueira HA; Bartolozzi A; Schell P; Litjens RE; Palmacci ER; Seeberger PH
    Chemistry; 2003 Jan; 9(1):140-69. PubMed ID: 12506372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of the heparin-based anticoagulant drug fondaparinux.
    Chang CH; Lico LS; Huang TY; Lin SY; Chang CL; Arco SD; Hung SC
    Angew Chem Int Ed Engl; 2014 Sep; 53(37):9876-9. PubMed ID: 25044485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overview of the current procedures in synthesis of heparin saccharides.
    Zhao S; Zhang T; Kan Y; Li H; Li JP
    Carbohydr Polym; 2024 Sep; 339():122220. PubMed ID: 38823902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward synthesis of the isosteric sulfonate analogues of the AT-III binding domain of heparin.
    Herczeg M; Lázár L; Borbás A; Lipták A; Antus S
    Org Lett; 2009 Jun; 11(12):2619-22. PubMed ID: 19473011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Replacement of the L-iduronic acid unit of the anticoagulant pentasaccharide idraparinux by a 6-deoxy-L-talopyranose - Synthesis and conformational analysis.
    Demeter F; Gyöngyösi T; Bereczky Z; Kövér KE; Herczeg M; Borbás A
    Sci Rep; 2018 Sep; 8(1):13736. PubMed ID: 30213971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentiation of anti-angiogenic activity of heparin by blocking the ATIII-interacting pentasaccharide unit and increasing net anionic charge.
    Chung SW; Lee M; Bae SM; Park J; Jeon OC; Lee HS; Choe H; Kim HS; Lee BS; Park RW; Kim SY; Byun Y
    Biomaterials; 2012 Dec; 33(35):9070-9. PubMed ID: 23010574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microarrays of heparin oligosaccharides obtained by nitrous acid depolymerization of isolated heparin.
    de Paz JL; Spillmann D; Seeberger PH
    Chem Commun (Camb); 2006 Aug; (29):3116-8. PubMed ID: 16855704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of heparin fragments: a methyl alpha-pentaoside with high affinity for antithrombin III.
    Petitou M; Duchaussoy P; Lederman I; Choay J; Jacquinet JC; Sinaÿ P; Torri G
    Carbohydr Res; 1987 Sep; 167():67-75. PubMed ID: 3690577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Cluster Sequencing Strategy To Determine the Consensus Affinity Domains in Heparin for Its Binding to Specific Proteins.
    Shi D; Sheng A; Bu C; An Z; Cui X; Sun X; Li H; Zhang F; Linhardt RJ; Zhang T; Jin L; Chi L
    Anal Chem; 2022 Oct; 94(40):13987-13994. PubMed ID: 36183273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasible synthesis and biological properties of six 'non-glycosamino' glycan analogues of the antithrombin III binding heparin pentasaccharide.
    Westerduin P; van Boeckel CA; Basten JE; Broekhoven MA; Lucas H; Rood A; van der Heijden H; van Amsterdam RG; van Dinther TG; Meuleman DG
    Bioorg Med Chem; 1994 Nov; 2(11):1267-80. PubMed ID: 7757423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An efficient synthesis of L-idose and L-iduronic acid thioglycosides and their use for the synthesis of heparin oligosaccharides.
    Tatai J; Osztrovszky G; Kajtár-Peredy M; Fügedi P
    Carbohydr Res; 2008 Mar; 343(4):596-606. PubMed ID: 18237719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microarrays of synthetic heparin oligosaccharides.
    de Paz JL; Noti C; Seeberger PH
    J Am Chem Soc; 2006 Mar; 128(9):2766-7. PubMed ID: 16506732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oligo(tyrosine sulfate)s as heparin pentasaccharide mimic: evaluation by surface noncovalent affinity mass spectrometry.
    Yamaguchi M; Ohmori T; Sakata Y; Ueki M
    Bioorg Med Chem; 2008 Mar; 16(6):3342-51. PubMed ID: 18160297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of the terminal P4 domain in a series of D-phenylglycinamide-based factor Xa inhibitors.
    Franciskovich JB; Masters JJ; Weber WW; Klimkowski VJ; Chouinard M; Sipes PR; Johnson LM; Snyder DW; Chastain MK; Craft TJ; Towner RD; Gifford-Moore DS; Froelich LL; Smallwood JK; Foster RS; Smith GF; Liebeschuetz JW; Murray CW; Young SC
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6910-3. PubMed ID: 17976987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a new potential mechanism responsible for severe bleeding in myeloma: immunoglobulins bind the heparin binding domain of antithrombin activating this endogenous anticoagulant.
    Martínez-Martínez I; González-Porras JR; Cebeira MJ; de Arriba F; Espín S; Bohdan N; Corrales FJ; Corral J; Vicente V
    Haematologica; 2016 Oct; 101(10):e423-e426. PubMed ID: 27479819
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthetic oligosaccharides having various functional domains: potent and potentially safe heparin mimetics.
    Petitou M; Driguez PA; Duchaussoy P; Hérault JP; Lormeau JC; Herbert JM
    Bioorg Med Chem Lett; 1999 Apr; 9(8):1161-6. PubMed ID: 10328305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversible biotinylated oligosaccharides: a new approach for a better management of anticoagulant therapy.
    Savi P; Herault JP; Duchaussoy P; Millet L; Schaeffer P; Petitou M; Bono F; Herbert JM
    J Thromb Haemost; 2008 Oct; 6(10):1697-706. PubMed ID: 18647228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A stereochemical surprise at the late stage of the synthesis of fully N-differentiated heparin oligosaccharides containing amino, acetamido, and N-sulfonate groups.
    Lohman GJ; Seeberger PH
    J Org Chem; 2004 Jun; 69(12):4081-93. PubMed ID: 15176833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.